Top

Surgery Today

Published in:

01-01-2012 | Original Article

The central vein access port and catheter in outpatient chemotherapy for colorectal cancer: a retrospective study of 101 patients

Authors: Hiroshi Sawayama, Naoko Hayashi, Masayuki Watanabe, Hiroshi Takamori, Toru Beppu, Hideo Baba

Published in: Surgery Today | Issue 1/2012

Abstract

Purpose

The central venous access port (CV-port) system was examined in a series of colorectal cancer (CRC) patients.

Methods

One hundred and one CRC patients underwent chemotherapy with the 5-fluorouracil + oxaliplatin (FOLFOX) or 5-fluorouracil + irinotecan regimen. The complications of the CV-port system were retrospectively assessed.

Results

The CV-port system was placed in a total of 101 patients. The patients received a total of 1035 courses of these regimens. Eight complications occurred in the 101 patients (7.9%). The complications included three instances of catheter rupture, two thrombotic events around the catheter, and three infections at the site of the port or catheter. The complications were identified after a median of nine courses (range 6–16) and 135 days after the placement of the CV-port system. Sixty-six of the 101 patients switched their regimen from FOLFOX to another regimen, and 4 of these 66 patients (6.1%) experienced complications associated with the CV-port system. There were 25 subjects who were admitted to the hospital emergency wing during the chemotherapeutic regimens, and 4 of these patients (16%) had complications associated with the CV-port system.

Conclusions

The complications of the CV-port system occurred at a defined rate, therefore the early diagnosis and the appropriate treatment to address these complications is crucial.

Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92:706–12.PubMed

Torramade JR, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Gonzalez J, et al. The complications of central venous access systems: a study of 218 patients. Eur J Surg. 1993;159:323–7.PubMed

Konno H, Yamamoto M, Ohta M. Recent concepts of antiangiogenic therapy. Surg Today. 2010;40:494–500.PubMedCrossRef

Cassidy J, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol. 2008;26:2006–12.PubMedCrossRef

Tsunoda A, Yasuda N, Nakao K, Narita K, Watanabe M, Matsui N, et al. Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer. Oncology. 2009;77:192–6.PubMedCrossRef

Ishida H, Miyake Y, Fukunaga M, Watanabe Y, Kato T, Takemoto H, et al. A feasibility study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304. Jpn J Clin Oncol. 2009;39:601–5.PubMedCrossRef

Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998;9:767–73.PubMedCrossRef

Charvat J, Linke Z, Horaekova M, Prausova J. Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience. Support Care Cancer. 2006;14:1162–5.PubMedCrossRef

Yip D, Funaki B. Subcutaneous chest ports via the internal jugular vein. A retrospective study of 117 oncology patients. Acta Radiol. 2002;43:371–5.PubMedCrossRef

10.

Funaki B, Szymski GX, Hackworth CA, Rosenblum JD, Burke R, Chang T, et al. Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. AJR Am J Roentgenol. 1997;169:1431–4.PubMedCrossRef

11.

Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ, Krzywda EA, Andris DA. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology. 1990;177:353–6.PubMed

12.

Andris DA, Krzywda EA, Schulte W, Ausman R, Quebbeman EJ. Pinch-off syndrome: a rare etiology for central venous catheter occlusion. JPEN J Parenter Enter Nutr. 1994;18:531–3.CrossRef

13.

Kawamura J, Nagayama S, Nomura A, Itami A, Okabe H, Sato S, et al. Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancer. Int J Clin Oncol. 2008;13:349–54.PubMedCrossRef

14.

Fazeny-Dorner B, Wenzel C, Berzlanovich A, Sunder-Plassmann G, Greinix H, Marosi C, et al. Central venous catheter pinch-off and fracture: recognition, prevention and management. Bone Marrow Transplant. 2003;31:927–30.PubMedCrossRef

15.

De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res. 1997;86:101–13.PubMedCrossRef

16.

Cortelezzi A, Moia M, Falanga A, Pogliani EM, Agnelli G, Bonizzoni E, et al. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol. 2005;129:811–7.PubMedCrossRef

17.

Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol. 2005;23:4057–62.PubMedCrossRef

18.

Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol. 2005;23:4063–9.PubMedCrossRef

19.

Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol. 2006;17:289–96.PubMedCrossRef

20.

Vescia S, Baumgartner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19:9–15.PubMedCrossRef

21.

Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect. 2002;8:265–74.PubMedCrossRef

22.

Ouriel K. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:2684–6 (author reply 2684–6).

23.

Kovacevich DS, Papke LF. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. Nutr Clin Pract. 2003;18:95–6.PubMedCrossRef

Title: The central vein access port and catheter in outpatient chemotherapy for colorectal cancer: a retrospective study of 101 patients
Authors: Hiroshi Sawayama
Naoko Hayashi
Masayuki Watanabe
Hiroshi Takamori
Toru Beppu
Hideo Baba
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: Surgery Today / Issue 1/2012
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI: https://doi.org/10.1007/s00595-011-0016-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The central vein access port and catheter in outpatient chemotherapy for colorectal cancer: a retrospective study of 101 patients

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Innovative segmentectomy to remove the posterior segment of the lower lobe (S10) of the lung

Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

Single-site laparoscopic herniorrhaphy using needle instruments for inguinal hernias in children: a novel technique

Stenting of a gastroduodenal artery aneurysm: report of a case

Side-to-side isoperistaltic strictureplasty for chronic ischemic enteritis: report of a case

Chylothorax after neck dissection for thyroid carcinomas: report of three cases